PILOCARPINE Side Effects

6607890-2 | Eye Swelling, Paraesthesia, Pruritus, Sinus Disorder
on Feb 25, 2010 Female patient from UNITED STATES , 66 years of age, weighting 165.0 lb, was treated with Pilocarpine (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, paraesthesia, pruritus, sinus disorder. Pilocarpine dosage: .

6356016-1 | Asthenia, Headache, Miosis, Retinal Tear, Vitreous Detachment
Patient was taking Pilocarpine (View Usage). Patient had the following side effects: asthenia, headache (What is headache?), miosis, retinal tear, vitreous detachment on Sep 14, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 150.4 lb, was diagnosed with glare, post procedural complication and. Pilocarpine dosage: 1% Pilocarpine, 1 Drop In Each Eye 1 Time Only 031. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PERCOCET (View Percocet Review and Percocet Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), MULTIVITIMIN (View Multivitimin Review and Multivitimin Label ).

6297244-3 | Fatigue, Feeling Abnormal, Insomnia, Odynophagia, Pharyngeal Disorder, Restless Legs Syndrome
Adverse event was reported on Aug 04, 2009 by a Female patient taking Pilocarpine (View Usage) (Dosage: 4x Per Day At Bedtime) . Location: UNITED STATES , weighting 104.3 lb, After Pilocarpine was administered, patient had the following side effects: fatigue, feeling abnormal, insomnia, odynophagia, pharyngeal disorder, restless legs syndrome.

6183922-3 | Dysphonia, Dyspnoea, Unevaluable Event
on May 06, 2009 Female patient from UNITED STATES , 51 years of age, weighting 160.0 lb, was treated with Pilocarpine (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, dyspnoea, unevaluable event. Pilocarpine dosage: 5 Mg Q 6.


5965037-X | Angle Closure Glaucoma, Cataract Operation, Intraocular Lens Implant, Intraocular Pressure Increased, Photocoagulation, Trabeculectomy, Visual Acuity Reduced
on Nov 14, 2008 Female patient from UNITED KINGDOM , 73 years of age, was diagnosed with intraocular pressure increased and was treated with Pilocarpine (View Usage). Patient had the following side effects: angle closure glaucoma, cataract operation, intraocular lens implant, intraocular pressure increased, photocoagulation, trabeculectomy, visual acuity reduced. Pilocarpine dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5965035-6 | Angle Closure Glaucoma, Cataract Operation, Intraocular Pressure Increased, Photocoagulation, Trabeculectomy, Visual Acuity Reduced
Patient was taking Pilocarpine (View Usage). After Pilocarpine was administered, patient had the following side effects: angle closure glaucoma, cataract operation, intraocular pressure increased, photocoagulation, trabeculectomy, visual acuity reduced on Nov 14, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with intraocular pressure increased and. Pilocarpine dosage: . During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5951584-3 | Corneal Oedema, Intraocular Pressure Increased
Adverse event was reported on Oct 31, 2008 by a Male patient taking Pilocarpine (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: AUSTRALIA , 73 years of age, Patient experienced the following unwanted or unexpected effects: corneal oedema, intraocular pressure increased. During the same period patient was treated with TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), IOPIDINE (View Iopidine Review and Iopidine Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

5898942-3 | Angle Closure Glaucoma
on Sep 11, 2008 Female patient from UNITED KINGDOM , 73 years of age, was diagnosed with intraocular pressure increased, cycloplegia, eye inflammation and was treated with Pilocarpine (View Usage). Patient had the following side effects: angle closure glaucoma. Pilocarpine dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), ATROPINE (View Atropine Review and Atropine Label ).

5897839-2 | Angle Closure Glaucoma, Cataract Operation, Intraocular Lens Implant, Intraocular Pressure Increased, Visual Acuity Reduced
on Sep 08, 2008 Female patient from UNITED KINGDOM , 73 years of age, was diagnosed with angle closure glaucoma and was treated with Pilocarpine (View Usage). After Pilocarpine was administered, patient had the following side effects: angle closure glaucoma, cataract operation, intraocular lens implant, intraocular pressure increased, visual acuity reduced. Pilocarpine dosage: Ophthalmic.

5896066-2 | Angle Closure Glaucoma
Patient was taking Pilocarpine (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma on Sep 11, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 80 years of age, was diagnosed with intraocular pressure increased, cycloplegia, eye inflammation and. Pilocarpine dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), ATROPINE (View Atropine Review and Atropine Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

5896064-9 | Angle Closure Glaucoma, Hyphaema, Iridocyclitis
Adverse event was reported on Sep 11, 2008 by a Male patient taking Pilocarpine (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased, cycloplegia, eye inflammation and. Location: UNITED KINGDOM , 27 years of age, Patient had the following side effects: angle closure glaucoma, hyphaema, iridocyclitis. During the same period patient was treated with TIMOLOL (View Timolol Review and Timolol Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), ATROPINE (View Atropine Review and Atropine Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

5865737-6 | Angle Closure Glaucoma, Cataract Operation, Intraocular Lens Implant, Intraocular Pressure Increased, Photocoagulation, Trabeculectomy, Visual Acuity Reduced
on Aug 21, 2008 Female patient from UNITED KINGDOM , 73 years of age, was diagnosed with intraocular pressure increased and was treated with Pilocarpine (View Usage). After Pilocarpine was administered, patient had the following side effects: angle closure glaucoma, cataract operation, intraocular lens implant, intraocular pressure increased, photocoagulation, trabeculectomy, visual acuity reduced. Pilocarpine dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5865724-8 | Angle Closure Glaucoma, Cataract Operation, Intraocular Pressure Increased, Photocoagulation, Trabeculectomy, Visual Acuity Reduced
on Aug 21, 2008 Male patient from UNITED KINGDOM , 78 years of age, was diagnosed with intraocular pressure increased and was treated with Pilocarpine (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma, cataract operation, intraocular pressure increased, photocoagulation, trabeculectomy, visual acuity reduced. Pilocarpine dosage: . During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5676270-9 | Angle Closure Glaucoma, Cataract, Choroidal Detachment, Corneal Touch
Patient was taking Pilocarpine (View Usage). Patient had the following side effects: angle closure glaucoma, cataract (What is cataract?), choroidal detachment, corneal touch on Mar 18, 2008 from Additional patient health information: Male patient , 51 years of age, was diagnosed with intraocular pressure increased, epilepsy (What is epilepsy?) and. Pilocarpine dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ), PHENOBARBITONE IP (View Phenobarbitone Ip Review and Phenobarbitone Ip Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

5633872-3 | Maculopathy, Retinal Disorder, Scotoma, Visual Acuity Reduced, Vitreous Detachment
Adverse event was reported on Feb 19, 2008 by a Female patient taking Pilocarpine (View Usage) (Dosage: ) was diagnosed with mydriasis and. Location: , 64 years of age, After Pilocarpine was administered, patient had the following side effects: maculopathy, retinal disorder (What is retinal disorder?), scotoma, visual acuity reduced, vitreous detachment.

5483994-5 | Activities Of Daily Living Impaired, Astigmatism, Cataract, Coma, Crying, Depression, Diplopia, Dry Eye
on Oct 09, 2007 Male patient from UNITED STATES , weighting 205.0 lb, was diagnosed with pupillary disorder and was treated with Pilocarpine (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, astigmatism, cataract (What is cataract?), coma, crying, depression (What is depression?), diplopia, dry eye. Pilocarpine dosage: 4 Drops Daily Occlusive Dressing. During the same period patient was treated with ALPHAGAN P (4 Drops Daily Occlusive Dressing) (View Alphagan P Review and Alphagan P Label ).

5307057-4 | Retinal Detachment, Vitreous Disorder
on Apr 20, 2007 Male patient from UNITED STATES , weighting 160.0 lb, was treated with Pilocarpine (View Usage). Patient had the following side effects: retinal detachment, vitreous disorder. Pilocarpine dosage: 1 Drop 3 Times Daily Ophthalmic. Patient was hospitalized and became disabled.

4707213-X | Dehydration, Diarrhoea
Patient was taking Pilocarpine (View Usage). After Pilocarpine was administered, patient had the following side effects: dehydration, diarrhoea on Jul 01, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 252.4 lb, was diagnosed with dry mouth and. Pilocarpine dosage: 5mg Qid Oral. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CALCIUM CARBONATE/VITAMIN D (View Calcium Carbonate/vitamin D Review and Calcium Carbonate/vitamin D Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), LUBRICANT, EYE OINT, (View Lubricant, Eye Oint, Review and Lubricant, Eye Oint, Label ), MECLIZINE (View Meclizine Review and Meclizine Label ). Patient was hospitalized.